N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine

C22H22N6S2 — CID 58627779

IUPACN-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine
SMILESc1ccc(NC2=N[C@@H](Cc3cnc[nH]3)CS2)c(CCNc2nc3ccccc3s2)c1
InChIInChI=1S/C22H22N6S2/c1-2-6-18(27-22-26-17(13-29-22)11-16-12-23-14-25-16)15(5-1)9-10-24-21-28-19-7-3-4-8-20(19)30-21/h1-8,12,14,17H,9-11,13H2,(H,23,25)(H,24,28)(H,26,27)/t17-/m0/s1
InChIKeyAUUZCSHAMGCSKF-KRWDZBQOSA-N
MW434.59 g/mol
LogP4.80
Rot. Bonds7

About N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine

N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine (PubChem CID 58627779) has the molecular formula C22H22N6S2 and a molecular weight of 434.59 g/mol. Its IUPAC name is N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine.

Molecular Properties

Compound NameN-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine
PubChem CID58627779
Molecular FormulaC22H22N6S2
Molecular Weight434.59 g/mol
Exact Mass434.13
IUPAC NameN-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine
SMILESc1ccc(NC2=N[C@@H](Cc3cnc[nH]3)CS2)c(CCNc2nc3ccccc3s2)c1
InChIInChI=1S/C22H22N6S2/c1-2-6-18(27-22-26-17(13-29-22)11-16-12-23-14-25-16)15(5-1)9-10-24-21-28-19-7-3-4-8-20(19)30-21/h1-8,12,14,17H,9-11,13H2,(H,23,25)(H,24,28)(H,26,27)/t17-/m0/s1
InChIKeyAUUZCSHAMGCSKF-KRWDZBQOSA-N
XLogP4.80
TPSA77.99 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500434.59
LogP ≤ 54.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine?
The IUPAC name of N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine (CID 58627779) is N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine.
What is the SMILES notation for N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine?
The canonical SMILES for N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine is c1ccc(NC2=N[C@@H](Cc3cnc[nH]3)CS2)c(CCNc2nc3ccccc3s2)c1.
What is the InChIKey of N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine?
The InChIKey is AUUZCSHAMGCSKF-KRWDZBQOSA-N. The full InChI is InChI=1S/C22H22N6S2/c1-2-6-18(27-22-26-17(13-29-22)11-16-12-23-14-25-16)15(5-1)9-10-24-21-28-19-7-3-4-8-20(19)30-21/h1-8,12,14,17H,9-11,13H2,(H,23,25)(H,24,28)(H,26,27)/t17-/m0/s1.
What are the key properties of N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine?
N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine has a molecular weight of 434.59 g/mol, XLogP of 4.80, 7 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[2-[[(4S)-4-(1H-imidazol-5-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]amino]phenyl]ethyl]-1,3-benzothiazol-2-amine is sourced from PubChem (CID 58627779), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).